Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000839890 | SCV000981800 | benign | not provided | 2018-06-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genome- |
RCV001702733 | SCV001933370 | benign | Hennekam lymphangiectasia-lymphedema syndrome 2 | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001703240 | SCV001933371 | benign | Van Maldergem syndrome 2 | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV003489933 | SCV004233163 | benign | not specified | 2024-01-24 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 66% of patients studied by a panel of primary immunodeficiencies. Number of patients: 63. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV000839890 | SCV005303326 | benign | not provided | criteria provided, single submitter | not provided |